Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 11:12 am Unchanged |
2021-12-31 | 13G | Ring Energy, Inc. REI |
Empery Asset Management, LP | 21,428,500 4.990% |
0 (Unchanged) |
Filing History |
| 2022-01-13 10:38 am Sale |
2021-12-31 | 13G | Red Cat Holdings, Inc. RCAT |
Empery Asset Management, LP | 0 0.000% |
-3,000,000 (Position Closed) |
Filing History |
| 2022-01-13 10:37 am Sale |
2021-12-31 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management, LP | 0 0.000% |
-33,333 (Position Closed) |
Filing History |
| 2022-01-13 10:36 am Sale |
2021-12-31 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 0 0.000% |
-1,100,000 (Position Closed) |
Filing History |
| 2022-01-13 10:36 am Sale |
2021-12-31 | 13G | Atossa Therapeutics, Inc. ATOS |
Empery Asset Management, LP | 1,312,500 1.030% |
-3,448,000 (-72.43%) |
Filing History |
| 2022-01-13 10:35 am Sale |
2021-12-31 | 13G | Applied DNA Sciences, Inc. APDN |
Empery Asset Management, LP | 0 0.000% |
-480 (Position Closed) |
Filing History |
| 2022-01-13 10:32 am Sale |
2021-12-31 | 13G | 22nd Century Group, Inc. XXII |
Empery Asset Management, LP | 0 0.000% |
-313 (Position Closed) |
Filing History |
| 2022-01-13 10:31 am Sale |
2021-12-31 | 13G | ENGlobal Corporation ENG |
Empery Asset Management, LP | 0 0.000% |
-297,619 (Position Closed) |
Filing History |
| 2022-01-13 10:31 am Sale |
2021-12-31 | 13G | VirTra, Inc. VTSI |
Empery Asset Management, LP | 0 0.000% |
-1,000,000 (Position Closed) |
Filing History |
| 2022-01-13 10:30 am Sale |
2021-12-31 | 13G | ION Geophysical Corporation IOGPQ |
Empery Asset Management, LP | 835 0.000% |
-995,832 (-99.92%) |
Filing History |
| 2022-01-13 10:30 am Sale |
2021-12-31 | 13G | Aethlon Medical, Inc. AEMD |
Empery Asset Management, LP | 10,500 0.680% |
-128,308 (-92.44%) |
Filing History |
| 2022-01-11 10:32 am Sale |
2021-12-31 | 13G | Vislink Technologies, Inc. VISL |
Empery Asset Management, LP | 151,515 3.200% |
-151,515 (-50.00%) |
Filing History |
| 2022-01-11 10:32 am Sale |
2021-12-31 | 13G | U.S. Energy Corp. USEG |
Empery Asset Management, LP | 0 0.000% |
-425,195 (Position Closed) |
Filing History |
| 2022-01-11 10:31 am Sale |
2021-12-31 | 13G | Orbital Infrastructure Group, Inc. OIG |
Empery Asset Management, LP | 0 0.000% |
-46,296 (Position Closed) |
Filing History |
| 2022-01-11 10:31 am Sale |
2021-12-31 | 13G | Lantern Pharma Inc. LTRN |
Empery Asset Management, LP | 0 0.000% |
-700,000 (Position Closed) |
Filing History |
| 2022-01-11 10:30 am Sale |
2021-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA |
Empery Asset Management, LP | 801,670 2.220% |
-428,330 (-34.82%) |
Filing History |
| 2021-08-20 4:40 pm Purchase |
2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Empery Asset Management, LP | 868,622 6.880% |
868,622 (New Position) |
Filing History |
| 2021-07-26 10:04 am Purchase |
2021-07-18 | 13G | Red Cat Holdings, Inc. RCAT |
Empery Asset Management, LP | 3,000,000 6.290% |
3,000,000 (New Position) |
Filing History |
| 2021-07-06 10:00 am Purchase |
2021-06-29 | 13G | Kiromic BioPharma, Inc. KRBP |
Empery Asset Management, LP | 33,333 6.500% |
33,333 (New Position) |
Filing History |
| 2021-06-28 10:01 am Purchase |
2021-06-22 | 13G | Second Sight Medical Products, Inc. EYES |
Empery Asset Management, LP | 1,100,000 8.710% |
1,100,000 (New Position) |
Filing History |